TRVN stock icon

Trevena
TRVN

$0.24
6.34%

Market Cap: 4.45M

 

About: Trevena Inc is an American biopharmaceutical company focused on developing and commercializing novel medicines for patients affected by central nervous system, or CNS, disorders.

Employees: 23

0
Funds holding %
of 6,702 funds
Analysts bullish %
0
News positive %
of 3 articles

Fund manager confidence

Based on 2024 Q1 SEC filings by fund managers ($100M+ AUM)

133% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 3

2.59% more ownership

Funds ownership: 9.58% [Q4 2023] → 12.17% (+2.59%) [Q1 2024]

2% less capital invested

Capital invested by funds: $1.05M [Q4 2023] → $1.03M (-$20K) [Q1 2024]

11% less funds holding

Funds holding: 27 [Q4 2023] → 24 (-3) [Q1 2024]

60% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 5

Research analyst outlook

2 Wall Street Analysts provided 1 year price forecasts over the past 6 months

Low target
$5
1,963%
upside
Avg. target
$7
2,788%
upside
High target
$9
3,613%
upside

2 analyst ratings

positive
100%
neutral
0%
negative
0%
HC Wainwright & Co.
Douglas Tsao
1,963%upside
$5
Buy
Maintained
16 May 2024
HC Wainwright & Co.
Douglas Tsao
3,613%upside
$9
Buy
Reiterated
11 Mar 2024

Financial journalist opinion

Based on 3 articles about TRVN published over the past 30 days